| Dr Elizabeth Ann Cilenti, MD | |
|
2445 Army Navy Dr Ste 400, Arlington, VA 22206-2988 | |
| (703) 379-8878 | |
| (703) 998-6821 |
| Full Name | Dr Elizabeth Ann Cilenti |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 2445 Army Navy Dr Ste 400, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124287776 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD040371 (District Of Columbia) | Secondary |
| 207R00000X | Internal Medicine | MD040371 (District Of Columbia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Georgetown University Hospital | Washington, DC | Hospital |
| Inova Alexandria Hospital | Alexandria, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Virginia Family Practice Associates | 6800872433 | 8 |
News Archive
KIKA Clinical Solutions, the leading provider of advanced EDC solutions for clinical trials, continues leading the industry in providing solutions that go well beyond traditional EDC with the release of Veracity™ 3.7.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the twelve months ended December 31, 2009, and affirmed its 2010 milestones of commencing up to five Phase 2 clinical trials with its oncology drug candidates.
Eminent UK reproductive and genetics experts have become the first in the world licensed to provide a revolutionary IVF procedure using donor DNA – which they spent decades developing – enabling women carrying potentially fatal mitochondrial disease to have healthy, genetically-related babies.
Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs' promising anti-cancer properties have been highlighted by a growing body of data in recent years.
› Verified 3 days ago
| Entity Name | Mgmc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891797148 PECOS PAC ID: 9537073119 Enrollment ID: O20031220000056 |
News Archive
KIKA Clinical Solutions, the leading provider of advanced EDC solutions for clinical trials, continues leading the industry in providing solutions that go well beyond traditional EDC with the release of Veracity™ 3.7.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the twelve months ended December 31, 2009, and affirmed its 2010 milestones of commencing up to five Phase 2 clinical trials with its oncology drug candidates.
Eminent UK reproductive and genetics experts have become the first in the world licensed to provide a revolutionary IVF procedure using donor DNA – which they spent decades developing – enabling women carrying potentially fatal mitochondrial disease to have healthy, genetically-related babies.
Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs' promising anti-cancer properties have been highlighted by a growing body of data in recent years.
› Verified 3 days ago
| Entity Name | Northern Virginia Family Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992869689 PECOS PAC ID: 6800872433 Enrollment ID: O20040625000089 |
News Archive
KIKA Clinical Solutions, the leading provider of advanced EDC solutions for clinical trials, continues leading the industry in providing solutions that go well beyond traditional EDC with the release of Veracity™ 3.7.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the twelve months ended December 31, 2009, and affirmed its 2010 milestones of commencing up to five Phase 2 clinical trials with its oncology drug candidates.
Eminent UK reproductive and genetics experts have become the first in the world licensed to provide a revolutionary IVF procedure using donor DNA – which they spent decades developing – enabling women carrying potentially fatal mitochondrial disease to have healthy, genetically-related babies.
Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs' promising anti-cancer properties have been highlighted by a growing body of data in recent years.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Ann Cilenti, MD 2445 Army Navy Dr Ste 400, Arlington, VA 22206-2988 Ph: (703) 379-8879 | Dr Elizabeth Ann Cilenti, MD 2445 Army Navy Dr Ste 400, Arlington, VA 22206-2988 Ph: (703) 379-8878 |
News Archive
KIKA Clinical Solutions, the leading provider of advanced EDC solutions for clinical trials, continues leading the industry in providing solutions that go well beyond traditional EDC with the release of Veracity™ 3.7.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the twelve months ended December 31, 2009, and affirmed its 2010 milestones of commencing up to five Phase 2 clinical trials with its oncology drug candidates.
Eminent UK reproductive and genetics experts have become the first in the world licensed to provide a revolutionary IVF procedure using donor DNA – which they spent decades developing – enabling women carrying potentially fatal mitochondrial disease to have healthy, genetically-related babies.
Ibuprofen, aspirin, and other non-steroidal anti-inflammatory medications are among the most commonly utilized medications in the United States. Primarily for treating pain, inflammation, and preventing cardiovascular disease, NSAIDs' promising anti-cancer properties have been highlighted by a growing body of data in recent years.
› Verified 3 days ago
Dr. Alvaro Andres Puig Rodriguez, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 425, Arlington, VA 22205 Phone: 703-717-4400 | |
Tiffany C Turner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 345, Arlington, VA 22205 Phone: 703-717-4400 Fax: 703-717-4401 | |
Dr. Anne Ruggles Pariser, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2921 11th St S, Arlington, VA 22204 Phone: 703-979-1400 | |
Dr. Michael Andrew Cole, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Intensive Care Unit, Arlington, VA 22205 Phone: 571-244-8410 | |
Robert Paul Holman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1635 N George Mason Dr, Suite 180, Arlington, VA 22205 Phone: 703-276-7798 Fax: 703-276-0433 | |
Dr. Irmindra S Rana, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 301, Arlington, VA 22204 Phone: 703-998-0480 Fax: 703-379-0449 | |
Dr. Ashok Chauhan, M.D., Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 511, Arlington, VA 22204 Phone: 703-379-4446 Fax: 703-379-0449 |